Back to search

Ireland· IE-PA-EU/1/23/1725/005-006

VAFSEO 450 mg Film-coated tablet

A vadadustat product containing vadadustat, registered in Ireland by Medice Arzneimittel Putter GmbH & Co. K.G. The same ATC class is registered in 13 of our 19 countries.

ATC B03XA08

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedVAFSEO 450 mg Film-coated tabletATCB03XA08REGISTER NO.IE-PA-EU/1/23/1725/00…PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Vadadustat is registered in 13 of 19 countries.

Countries holding a registration under ATC B03XA08 (vadadustat), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose

Vadadustat · ATC B03XA08

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vadadustat costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Vadadustat · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$15.64
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Vadadustat
Manufacturer
Medice Arzneimittel Putter GmbH & Co. K.G
Country
Ireland (IE)
ATC code
B03XA08
ATC class
Vadadustat
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/23/1725/005-006

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Vadadustat in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vadadustat products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Vafseo
  • Norway · Vafseo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f2040d2a-9468-43c8-9b70-3757b9ae5fba
GET /v1/drugs/f2040d2a-9468-43c8-9b70-3757b9ae5fba?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "B03XA",
    "B03XA08"
  ],
  "strength": null,
  "pa_number": "EU/1/23/1725/005-006",
  "substances": [
    "Vadadustat"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "24/04/2023",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about vadadustat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.